Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway
<b>Background/Objectives:</b> Studies have shown that Atractylenolide I (AT-I) can exert anti-inflammatory and anti-oxidative effects, protecting against the development of various kinds of cardiovascular diseases. However, whether AT-I prevents nicotine-induced atherogenesis is unknown....
Saved in:
| Main Authors: | Huan-Huan Li, Xian Liu, Yu-Ping Wang, Xi Xu, Lin Zhu, Wei Zhang, Kun Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/5/329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
by: Cai Weiran, et al.
Published: (2025-08-01) -
Sophora moocroftiana seeds ethanol extract regulates NLRP3 inflammasome activation and pyroptosis via ROS/TXNIP pathway to amelioration of NAFLD in vitro and in vivo
by: Ruiying Yuan, et al.
Published: (2025-08-01) -
Macrophage pyroptosis in atherosclerosis: therapeutic potential
by: Ma Jianying, et al.
Published: (2025-02-01) -
LPS-induced extracellular AREG triggers macrophage pyroptosis through the EGFR/TLR4 signaling pathway
by: Gang Yuan, et al.
Published: (2025-04-01) -
Insights into the pathogenesis of nicotine addiction. Could a salivary biosensor be useful in Nicotine Replacement Therapy (NRT)?
by: Anida-Maria Băbțan, et al.
Published: (2019-10-01)